Department of Pathology,
Department of Immunology,
Duke Human Vaccine Institute
Herman F. Staats has not added Biography.
If you are Herman F. Staats and would like to personalize this page please email our Author Liaison for assistance.
Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization.
Journal of virology Jan, 2002 | Pubmed ID: 11752142
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF.
Vaccine May, 2002 | Pubmed ID: 12009296
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
The Journal of infectious diseases Apr, 2003 | Pubmed ID: 12660916
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection.
Nature immunology Dec, 2003 | Pubmed ID: 14595438
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.
Journal of virology Dec, 2004 | Pubmed ID: 15542668
Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
Microbiology and immunology , 2005 | Pubmed ID: 15722596
Mucosal and systemic adjuvant activity of alphavirus replicon particles.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2006 | Pubmed ID: 16505353
Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines.
AIDS research and human retroviruses Jun, 2006 | Pubmed ID: 16796531
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.
Clinical and vaccine immunology : CVI Nov, 2006 | Pubmed ID: 16943347
Oral immunogenicity of the plant proteinase bromelain.
International immunopharmacology Dec, 2006 | Pubmed ID: 17161360
Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
AAPS PharmSciTech Jan, 2007 | Pubmed ID: 17408218
In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
Infection and immunity Nov, 2007 | Pubmed ID: 17709410
Mast cell activators: a new class of highly effective vaccine adjuvants.
Nature medicine May, 2008 | Pubmed ID: 18425129
An entirely cell-based system to generate single-chain antibodies against cell surface receptors.
Journal of molecular biology May, 2008 | Pubmed ID: 18455737
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.
Journal of immunology (Baltimore, Md. : 1950) Jul, 2008 | Pubmed ID: 18566424
Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.
Vaccine Aug, 2008 | Pubmed ID: 18582997
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.
Vaccine Sep, 2008 | Pubmed ID: 18656518
Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library.
Journal of immunological methods Jan, 2009 | Pubmed ID: 19017532
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen.
Vaccine Jun, 2009 | Pubmed ID: 19464533
Mast cell-derived particles deliver peripheral signals to remote lymph nodes.
The Journal of experimental medicine Oct, 2009 | Pubmed ID: 19808250
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues.
Cell host & microbe Oct, 2009 | Pubmed ID: 19837373
Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide.
Clinical and vaccine immunology : CVI Mar, 2010 | Pubmed ID: 20107010
Adenovirus F protein as a delivery vehicle for botulinum B.
BMC immunology Jul, 2010 | Pubmed ID: 20609248
Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.
Vaccine Oct, 2010 | Pubmed ID: 20723629
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
AIDS research and human retroviruses May, 2011 | Pubmed ID: 21091128
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits.
PloS one Jan, 2011 | Pubmed ID: 21304600
Cytokines: the future of intranasal vaccine adjuvants.
Clinical & developmental immunology , 2011 | Pubmed ID: 21826181
Stable dry powder formulation for nasal delivery of anthrax vaccine.
Journal of pharmaceutical sciences Jan, 2012 | Pubmed ID: 21905034
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes.
Nature materials Jan, 2012 | Pubmed ID: 22266469
Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2012 | Pubmed ID: 22345651
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.
Vaccine Mar, 2013 | Pubmed ID: 23352329
Evaluation of vaccine-induced antibody responses: impact of new technologies.
Vaccine Jun, 2013 | Pubmed ID: 23583812
Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.
Journal of virology Jun, 2013 | Pubmed ID: 23596289
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents.
MedChemComm Jan, 2013 | Pubmed ID: 23667736
A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.
Peptides Oct, 2013 | Pubmed ID: 23891650
Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP.
Immunity Dec, 2013 | Pubmed ID: 24332031
Which comes first: the antigen or the adjuvant?
The Journal of clinical investigation Jun, 2014 | Pubmed ID: 24837429
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity.
Scientific reports Jun, 2014 | Pubmed ID: 24894817
Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination.
Vaccine Jul, 2015 | Pubmed ID: 26087299
Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.
Vaccine Aug, 2015 | Pubmed ID: 26144902
Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.
Vaccine Feb, 2016 | Pubmed ID: 26812077
Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.
Journal of virology May, 2016 | Pubmed ID: 26937027
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity.
Journal of controlled release : official journal of the Controlled Release Society Sep, 2015 | Pubmed ID: 27005208
Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge.
Clinical and vaccine immunology : CVI 07, 2016 | Pubmed ID: 27146001
Assessing the satisfaction and burden within an academic animal care and use program.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 09, 2017 | Pubmed ID: 28515151
Effect of endotoxin and alum adjuvant vaccine on peanut allergy.
The Journal of allergy and clinical immunology 02, 2018 | Pubmed ID: 28927819
Vaccine adjuvants: Softness makes it better.
Nature materials 01, 2018 | Pubmed ID: 29358771
Mast cell activators as novel immune regulators.
Current opinion in pharmacology 08, 2018 | Pubmed ID: 29843056
Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles.
Science (New York, N.Y.) 11, 2018 | Pubmed ID: 30409859
Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice.
Allergy 11, 2019 | Pubmed ID: 30746720
Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening.
SLAS discovery : advancing life sciences R & D 07, 2019 | Pubmed ID: 30917061
Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
Journal of virology 07, 2019 | Pubmed ID: 31068425
Softness makes it better.
Nature materials Feb, 2018 | Pubmed ID: 31745266
Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy.
NPJ vaccines , 2020 | Pubmed ID: 32047657
Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy.
NPJ vaccines Feb, 2020 | Pubmed ID: 33536438
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유